Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics (KPTI) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• KPTI last traded at $0.09, -21.34% on the day.
• Karyopharm Therapeutics: market cap $2.54M, P/E -0.0, revenue $146.62M over the last four quarters, next earnings 2027-02-10.
• Over the past year KPTI returned -98.48%; year to date -98.80%.

Updated 2026-11-04 07:10 UTC